Biogen, Inc (BIIB) Covered Calls

Biogen, Inc covered calls Biogen Idec Inc. is a global biotechnology Company that creates new standards of care in therapeutic areas with high unmet medical needs.

You can sell covered calls on Biogen, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BIIB (prices last updated Mon 4:16 PM ET):

Biogen, Inc (BIIB) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
232.48 +1.21 232.22 232.45 1.2M 10 45B
Covered Calls For Biogen, Inc (BIIB)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Aug 16 230 8.80 223.65 2.8% 39.3%
Oct 18 230 14.30 218.15 5.4% 22.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Biogen, Inc. is a global biotechnology company, which develops markets and manufactures therapies for people living with neurological, autoimmune and hematologic disorders. Its products include AVONEX, PLEGRIDY, TECFIDERA, TYSABRI, and FAMPYRA for multiple sclerosis, ALPROLIX for hemophilia B and ELOCTATE for hemophilia A. The company also collaborates on the development and commercialization of RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and other conditions and share profits and losses for GAZYVA which is approved for the treatment of chronic lymphocytic leukemia. Biogen was founded on November 12, 2003 and is headquartered in Cambridge, MA.